The Study

The NORDIC Rectal Prolapse Study is an international, prospective, observational multicentre cohort study evaluating patient-reported and clinical outcomes after surgery for external rectal prolapse.

BACKGROUND

Why is NORDIC needed?

External rectal prolapse can have a substantial impact on quality of life, including symptoms of faecal incontinence, constipation and discomfort. Several surgical techniques are used, but high-quality comparative evidence remains limited. Historically, surgical research has often focused on recurrence, while patients also place considerable importance on symptom relief, safety and quality of life.

NORDIC aims to strengthen the evidence available to patients and surgeons when choosing a surgical treatment.

SCIENTIFIC OVERVIEW

The study at a glance

NORDIC is designed to compare patient-reported and clinical outcomes following different surgical approaches for external rectal prolapse in routine practice.

Population

Adults undergoing surgery for external rectal prolapse, with the ability to provide informed consent.

Design

Prospective, international multicentre observational cohort. Surgical approach follows routine clinical decisions, without random allocation.

Primary comparison

Outcomes of established surgical procedures compared with laparoscopic ventral mesh rectopexy, with emphasis on patient-reported health status.

Key assessments

EQ-5D at six months; bowel function and other patient-reported outcomes, with further follow-up over time.

Further details about endpoints, participating procedures, eligibility and follow-up are described below. Protocol-defined analyses and assessment timing take precedence over this simplified overview.

STUDY AIM

Comparing outcomes that matter to patients

The primary objective is to determine whether established procedures for external rectal prolapse are non-inferior to laparoscopic ventral mesh rectopexy (LVMR) in terms of generic health status, assessed using EQ-5D at six months after surgery.

The study also investigates constipation, faecal incontinence, other functional outcomes, complications, recurrence and health-economic outcomes.

STUDY DESIGN

International, multicentre and observational

430

Planned participants

Prospective study cohort

International

Multicentre study

Collaboration across surgical centres

Observational

Routine clinical care

No random allocation to surgery

NORDIC is a prospective observational cohort study with an enhanced design. Surgical treatment is selected as part of routine clinical care rather than assigned by randomisation. The protocol includes different approaches to surgery for external rectal prolapse, including laparoscopic ventral mesh rectopexy, posterior suture rectopexy, resection rectopexy and perineal procedures.

The study has a planned sample size of 430 participants. Eligible participants are adults aged 18 years or older undergoing surgery for external rectal prolapse who can provide valid informed consent. The study does not require additional clinical visits or investigations outside routine care.

OUTCOME MEASURES

Quality of life, bowel function and surgical outcomes

Quality of life

Generic health status (EQ-5D)

Bowel function

Constipation, incontinence and patient-prioritised symptoms

Surgical outcomes

Complications, recurrence and recovery

Primary outcome: Change in generic health status measured with EQ-5D at six months after surgery. The protocol also identifies PAC-SYM at 12 months as an additional primary endpoint.

Other outcomes: Constipation (PAC-SYM), faecal incontinence (Wexner score), patient-prioritised symptoms (MYMOP2), urinary and sexual function, pain, global satisfaction, recurrence, perioperative complications, length of stay, readmissions and health-economic measures.

DATA COLLECTION AND FOLLOW-UP

Following patients beyond surgery

Before surgery

Baseline PROMs within 3 months before surgery

Surgery

Operative and perioperative data

30 days after

Clinical outcomes

6 months after

Key patient-reported follow-up

The protocol also describes optional follow-up at 12 months, 3 years and 5 years.

The key postoperative patient-reported assessment is at six months after surgery. Additional follow-up allows the study to examine outcomes over time.

Patient questionnaires can be completed electronically or on paper. Study data are collected in REDCap using study identifiers, with identifying information retained securely at each participating site.

PROJECT MILESTONES

Our study journey

From international collaboration and recruitment to long-term follow-up and sharing the results. This overview shows project phases rather than individual patient appointments; no completion dates are implied.

1

Study setup

Study protocol, participating centres and international collaboration.

2

ONGOING

Recruitment

Including eligible patients and recording baseline and surgical data.

3

ONGOING

Follow-up

Collecting outcomes at six months and later assessments as participants reach them.

4

Analysis & publications

Analysing the completed dataset and sharing findings with patients and clinicians.

Recruitment and follow-up may take place at the same time across participating centres. See the homepage for the latest manually verified recruitment figures.

Further information

For study-related enquiries, please contact the NORDIC coordinating team.

andsfe@rm.dk

ClinicalTrials.gov registration: NCT05569980